Differential effects of nicorandil on the vasodepressor responses to vasoactive polypeptides administered intravenously to rats

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 2, 1998, Pages 211-214

  Sakai, Kazushige ^a   Akima, Michitaka ^a   Saito, Keiji ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CALCITONIN GENE RELATED PEPTIDE; GLIBENCLAMIDE; NICORANDIL; POTASSIUM CHANNEL; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DEPRESSOR RESPONSE; DRUG EFFECT; DRUG INFUSION; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; RAT;

EID: 0031887986     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb06178.x     Document Type: Article

References (15)

1. + channel opening and guanylate cyclase stimulation to its vasorelaxant effect on various endothelin-1-contracted arterial preparations, comparison to aprikalim (RP 52891) and nitroglycerine. J. Pharmacol. Exp. Ther. 259: 526-534
2. Cavero, I., Mondot, S., Mestre, M. (1989) Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels. J. Pharmacol. Exp. Ther. 248: 1261-1268
3. Elhawary, A. M., Poon, J., Pang, C. C. Y. (1995) Effects of calcitonin gene-related peptide receptor antagonists on renal actions of adrenomedullin. Br. J. Pharmacol. 115: 1133-1140
4. 2 receptor-mediated vasodepression does not involve a pertussis toxin-sensitive G protein. Eur. J. Pharmacol. 236: 255-262
5. Gibbins, I. L., Fumess, J. B., Costa, M., MacIntyre, I., Hillyard, C. J., Girgis, S. (1985) Co-localization of calcitonin gene-related peptide-like immunoreactivity with substance P in cutaneous, vascular and visceral sensory neurons of guinea pigs. Neurosci. Lett. 57: 125-130
6. Gulbenkian, S., Merighi, A., Wharton, J., Varndell, I. M., Polak, J. M. (1986) Ultrastructural evidence for the coexistence of calcitonin gene-related peptide (CGRP) and substance P (SP) in secretory vesicles in the peripheral nervous system of guinea pig. J. Neurocytol. 15: 535-542
7. Hamilton, T. C., Weston, A. H. (1989) Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle. Gen. Pharmacol. 20: 1-9
8. Kinoshita, M., Sakai, K. (1990) Pharmacology and therapeutic effects of nicorandil. Cardiovasc. Drugs Ther. 4: 1075-1088
9. Krumenacker, M., Roland, E. (1992) Clinical profile of nicorandil: an overview of its haemodynamic properties and therapeutic efficacy. J. Cardiovasc. Pharmacol. 20: S93-S102
10. + Channels in Cardiovascular Medicine. Springer, France, pp 95-106
11. Rubino, A., Burnstock, G. (1996) Capsaicin-sensitive sensory-motor neurotransmission in the peripheral control of cardiovascular function. Cardiovasc. Res. 31: 467-479
12. Saito, K., Sakai, K. (1998) Enhancement of the vasodepressor response to adenosine by nicorandil in rats: comparison with nicorandil. Fundam. Clin. Pharmacol. 12: 37-43
13. Sakai, K. (1989) Nicorandil: animal pharmacology. Am. J. Cardiol. 63: 2J-10J
14. + channels in arterial smooth muscle. Science 245: 177-180
15. Taira, N. (1989) Nicorandil as a hybrid between nitrates and potassium channel activators. Am. J. Cardiol. 63: 18J-24J